Hepatic I/r Injury Model
Hepatic I/r Injury Model - Related Videos
06:51
A Preclinical Murine Model of Hepatic Metastases
0 Views •
Cited by 119 •
2014
A preclinical, murine model of hepatic metastases performed via a hemispleen injection technique.
10:40
Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
0 Views •
Cited by 10 •
2012
An optical system was developed to visualize hepatic microcirculation with FITC-labeled erythrocytes and to measure the partial pressure of oxygen in the microvessels with laser-assisted phosphorimetry. This method can be used to investigate physiological and pathological mechanisms by analyzing microvascular structure, diameter, blood flow velocity, and oxygen tension.
05:23
Murine Bioluminescent Hepatic Tumour Model
0 Views •
Cited by 11 •
2010
This article describes a procedure for the induction of orthotopic bioluminescent liver tumours in mice, and subsequent analysis of tumour growth confined to the liver using live whole body luminescence imaging.
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
0 Views •
Cited by 31 •
2012
Infection of mice with an Adenovirus expressing the major human autoantigen cytochrome P450 2D6 (hCYP2D6) recognized by sera of patients suffering from type 2 autoimmune hepatitis results in a persistent form of autoimmune-mediated liver disease characterized by extensive hepatitis, fibrosis and generation of a CYP2D6-specific immune response.
04:19
A Mouse Model of Single and Repetitive Mild Traumatic Brain Injury
0 Views •
Cited by 16 •
2017
Athletes absorb several hundred mild traumatic brain injuries (mTBI)/concussions every year; however, the consequence of these on the brain is poorly understood. Therefore, an animal model of single and repetitive mTBI that consistently replicates clinically relevant symptoms provides the means to advance the study of mTBI and concussion.
FAQs
During ischemia, reduced oxygen availability disrupts cellular energy production in liver tissue. This loss of energy compromises normal cell maintenance and creates conditions that make hepatocytes vulnerable when circulation returns. The model therefore separates the initial metabolic stress from later reperfusion-associated events, helping investigators examine how oxygen interruption contributes to acute liver damage.
Restoring blood flow introduces conditions that increase reactive oxygen species, chemically active molecules that can damage cellular components. Their accumulation is linked with mitochondrial dysfunction and promotes downstream inflammatory signaling. Examining this transition is important because injury does not end when circulation resumes; reperfusion can intensify the damage initiated during ischemia.
Mitochondrial dysfunction connects disrupted energy production with worsening cellular injury during hepatic I/R. At the same time, inflammatory signaling amplifies the tissue response after reperfusion and contributes to hepatocyte death. Assessing these linked mechanisms allows a model to evaluate whether an intervention protects liver cells by preserving cellular function, limiting inflammation, or addressing both processes.
Investigators assess biochemical, histological, and functional changes in the liver. Biochemical findings indicate injury-associated alterations, histological examination reveals tissue damage, and functional measurements show how well the liver performs after the ischemic and reperfusion challenge. Considering these outcome types together provides a broader evaluation than relying on a single indicator of tissue injury.
The model is relevant to clinical situations in which liver blood flow is temporarily interrupted and later restored. Its main contexts include surgery, transplantation, and shock. By reproducing important features of these conditions experimentally, researchers can investigate acute liver damage and evaluate strategies intended to reduce injury or improve recovery after procedures involving temporary vascular occlusion.
Researchers can use the system to compare liver responses with and without a proposed protective strategy, then examine biochemical, histological, and functional outcomes. Improvements across these measures may indicate reduced tissue injury or better liver performance. This approach helps connect mechanistic findings, such as reduced oxidative or inflammatory damage, with outcomes relevant to transplantation and other clinical settings.